Advisor Net Financial, Inc Bluebird Bio, Inc. Transaction History

Advisor Net Financial, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$8.96 - $16.31 $20,518 - $37,349	-2,290 Closed	0 $0
Q2 2021 Jul 06, 2021	SELL	$18.04 - $22.09 $11,816 - $14,468	-655 Reduced 22.24%	2,290 $73,000
Q1 2021 Apr 14, 2021	BUY	$16.59 - $33.89 $30,542 - $62,391	1,841 Added 166.76%	2,945 $89,000
Q4 2020 Feb 04, 2021	BUY	$27.5 - $37.92 $8,360 - $11,527	304 Added 38.0%	1,104 $48,000
Q4 2017 Feb 27, 2018	BUY	$81.25 - $130.7 $65,000 - $104,559	800	800 $142,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.